2020/4 GaBI Journal Table of Contents

Contents

Editor’s Letter

Medical journal publication during global stress

Editorial

Is the local tolerance of injectable biosimilars too underestimated?

Commentary

A white paper: US biosimilars market on pace with Europe

Original Research

Physicochemical stability of the bevacizumab biosimilar, ABP 215, after preparation and storage in intravenous bags

Local policies on biosimilars: are they designed to optimize use of liberated resources?

Review Article

Pharmaceutical Data Integrity: issues, challenges and proposed solutions for manufacturers and inspectors

Perspective

Can local policies on biosimilars optimize the use of freed resources – experiences from Italy

Source URL: https://gabi-journal.net/2020-4-gabi-journal-table-of-contents.html


Generics and Biosimilars Initiative (GaBI)
Tel: +32 474989572 | Fax: +32 14 583 048